Documentation Immunization Specialty Pharmacies 
Drug Topics
JUNE 11, 2025
The study cohort included 670 patients who were diagnosed with PsA of at least a 3 month duration and have active plaque psoriatic skin lesions or a documented medical history of plaque psoriasis. READ MORE: Significant Knowledge Gap Exists in Patient Awareness of Psoriatic Disease The study found that 54.2%
Drug Topics
JUNE 11, 2025
1 “Psoriasis is a chronic disease in which the immune system becomes overactive, causing skin cells to multiply too quickly,” wrote the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This led researchers to explore a specific region of the world in order to better document patients’ understanding of the disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 25, 2025
image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. 1 “Guidelines recommend treating obesity with medications and lifestyle changes.”
Drug Topics
JULY 1, 2025
That means a robust immunization program for COVID-19, flu, shingles, pneumococcal and beyond. Pharmacists can get trained credentials, get up to speed and enrolled to generate $20, $30, $50 a month per patient in managing their medications a little better and documenting it. Medication therapy management services.
PQA
NOVEMBER 14, 2024
Chief Executive Officer Micah Cost opened the summit with an update on the state of the alliance. Cost highlighted progress towards completion of PQA’s strategic plan, Blueprint PQA 2025. Each panel session featured PQA staff and pilot project participants or other industry leaders, who detailed their approach, experience and outcomes.
PQA
SEPTEMBER 25, 2023
We continue to play a central role in driving meaningful improvements and positive changes related to medication safety, adherence and appropriate use.The 2023 PQA Annual Report documents our progress towards Blueprint PQA 2025. The data can also show short term results.
Drug Topics
JULY 8, 2025
TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” The next step consists of treatment with topical anti-inflammatory therapies. Above all other medication classes and formulations, TCSs have been deemed as the most important pharmacotherapy in the treatment of AD.
Expert insights. Personalized for you.
315 
Let's personalize your content